MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by SLAVÍK, K.
Right arrow Articles by NOVÁKOVÁ, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by SLAVÍK, K.
Right arrow Articles by NOVÁKOVÁ, E.

Molecular Pharmacology, Vol 5, 137-147, Copyright © 1969 by the American Society for Pharmacology and Experimental Therapeutics

Azahomoaminopterin, a New Type of Folic Acid Antimetabolite

K. SLAVÍK 1, V. SLAVÍKOVÁ 1, K. MOTYCcaronKA 1, E. HERMANOVÁ 1, J. SOUCcaronEK 1, Z. TOMSOVÁ 1, M. ScaronPUNDOVÁ 1, and E. NOVÁKOVÁ 1

1 Laboratory of Protein Metabolism, School of Medicine, Charles’ University, and Institute of Hematology and Blood Transfusion, Prague, Czechoslovakia

Several new folic acid and aminopterin analogues were synthesized, in which the aliphatic chain binding the pteridine and aromatic nucleus was extended by 1 nitrogen atom. Condensation of 2-amino-4-hydroxypteridine-6-aldehyde with p-hydrazinobenzoylglutamate gave a hydrazone whose carbon-nitrogen double bond was reduced by sodium borohydride to form 11-azahomofolic acid. 11-Azahomopteroic acid was prepared by the condensation of 2-amino-4-hydroxypteridine-6-aldehyde with p-hydrazinobenzoic acid and subsequent reduction of the hydrazone with sodium borohydride. 11-Azahomoaminopterin and 4-aminoazahomopteroic acid were prepared in the same manner, using 2,4-diaminopteridine-6-aldehyde as the starting compound. The 5,6,7,8-tetrahydro derivatives of azahomofolic acid and azahomoaminopterin were prepared by catalytic hydrogenation of the parent compounds in glacial acetic acid.

Azahomopteroic acid and related compounds showed no significant inhibitory effect on HeLa cells grown in tissue culture, or any toxicity for mice in doses up to 100 mg/kg. Azahomoaminopterin, its parent hydrazone, and analogous pteroic acid derivatives exhibited a marked cytostatic effect on HeLa cells and were toxic for mice in doses exceeding 100 mg/kg, whereas 4-aminoazahomopteroic acid and its parent hydrazone showed no toxicity when administered in the same doses.

Among the enzymes interconverting folic acid or involving tetrahydrofolate as a coenzyme, thymidylate synthetase was inhibited slightly by azahomoaminopterin and more strongly by its tetrahydro derivative, the inhibition being noncompetitive versus tetrahydrofolate.

Folate reductase from mouse liver was inhibited by all the analogues containing an NH2 group in position 4 (azahomoaminopterin and related substances). Azahomofolic acid and its derivatives were ineffective. Other tetrahydrofolate-interconverting enzyme systems and purine biosynthesis were not inhibited by any of the compounds studied.

Submitted on September 18, 1968







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1969 by the American Society for Pharmacology and Experimental Therapeutics